34.89
+3.02
+(9.48%)
At close: 4:00:01 PM EDT
34.89
0.00
(0.00%)
After hours: 4:05:06 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | -0.57 | -0.62 | -2.63 | -1.94 |
| Low Estimate | -0.68 | -0.81 | -3.54 | -2.2 |
| High Estimate | -0.44 | -0.45 | -1.89 | -1.68 |
| Year Ago EPS | -0.5 | -0.5 | -4.11 | -2.63 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | 2.3M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 5.41M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.85 | -0.47 | -1.17 | -0.42 |
| EPS Actual | -0.5 | -0.5 | -1.85 | -2.75 |
| Difference | 0.35 | -0.03 | -0.68 | -2.33 |
| Surprise % | 41.18% | -7.14% | -58.12% | -554.76% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.57 | -0.62 | -2.63 | -1.94 |
| 7 Days Ago | -0.53 | -0.59 | -2.48 | -0.24 |
| 30 Days Ago | -0.53 | -0.59 | -2.48 | -0.24 |
| 60 Days Ago | -0.57 | -0.63 | -2.65 | -0.24 |
| 90 Days Ago | -0.54 | -0.62 | -2.68 | -0.53 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 2 | 2 |
| Down Last 30 Days | 2 | 2 | -- | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MNPR | -13.33% | -24.00% | 35.93% | 26.33% |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Downgrade | Jones Trading: Buy to Hold | 4/2/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/22/2025 |
| Initiated | Piper Sandler: Overweight | 1/10/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/11/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/14/2024 |
Related Tickers
DRUG Bright Minds Biosciences Inc.
28.83
+0.24%
FBRX Forte Biosciences, Inc.
5.25
-10.87%
TVTX Travere Therapeutics, Inc.
14.50
+7.49%
SNDX Syndax Pharmaceuticals, Inc.
11.16
+6.08%
JANX Janux Therapeutics, Inc.
28.80
+7.18%
MRUS Merus N.V.
41.97
+8.67%
CADL Candel Therapeutics, Inc.
4.9700
+4.19%
PRTG Portage Biotech Inc.
8.59
+70.44%
FENC Fennec Pharmaceuticals Inc.
5.01
0.00%
TIL Instil Bio, Inc.
15.03
+5.99%